If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Interim Results

27 Sep 2006 07:00

Omega Diagnostics Group PLC27 September 2006 Omega Diagnostics Group PLC 26-Sep-2006 Omega Diagnostics Group PLC (formerly Quintessentially English PLC) (the "Company") Interim Results The Company announces its interim results for the six month period to 30th June2006. These interim results do not include any results for Omega DiagnosticsLimited ("Omega"), the acquisition of which was announced on 24th August 2006and unanimously approved by shareholders at the EGM on 18th September 2006. Since the Company's Admission to AIM in March 2004 it has continued to evaluatea number of potential acquisitions and this has resulted in the purchase ofOmega. During the six months ended 30th June 2006, there was a turnover in respect ofthe Company (excluding Omega) of £Nil, and a loss after tax of £73,218, the bulkof which related to abort fees incurred on prospective acquisitions paid toadvisers undertaking due diligence. No Company directors received anyremuneration during the period and no dividend is recommended. The future Omega manufactures and distributes test kits for tropical and other diseases ona global basis, selling product through a strong distribution network in over100 countries and which it has been involved in for the past 19 years. Omega hasidentified a number of prospective and related acquisitions and intends to growin this way. Michael Gurner will be staying on as a non-executive director and Robert Coe andGraham Ashley have resigned following the EGM. David Evans has become Chairmanand Andrew Shepherd and Kieron Harbinson have joined the Board as ChiefExecutive and Finance Director respectively. For further information: Omega Diagnostics Group PLCMr Michael Gurner, 07768 231 731 Profit and Loss AccountFor the period 01/01/06 to 30/06/06 Note Period Ended 30/06 Period Ended 30/06 /2006 (unaudited) /2005 (unaudited) £ £ Turnover - -Administrative expenses (75,850) (60,633)Operating Loss (75,850) (60,633)Interest Receivable 2,674 4,382Interest Payable (42) (32)Loss on ordinary activities before taxation 1 (73,218) (56,283)Taxation - -Loss on ordinary activities after taxation (73,218) (56,283)Basic and diluted earnings per Ordinary share (pence) (0.66) (0.50)Dividends per share (pence) 0 0 Balance SheetAs at 30/06/06 Note 30/06/2006 30/06/2005 (unaudited) (unaudited) £ £ £ £ Fixed AssetsInvestments 2 2Current AssetsPrepayments 3,825 0Cash at bank in hand 124,820 198,277Current LiabilitiesCreditors: Amounts falling (80,122) (48,120)due within one yearNet current assets 48,523 150,157Total assets less current 48,525 150,159liabilitiesCalled up share capital 2 111,769 111,769Share premium 3 167,867 167,867Profit and loss account (231,111) (129,477)Equity shareholders funds 48,525 150,159Net assets per share (pence) 4 0.43p 1.34p Cash Flow Statement For the period from 01/01/06 to 30/06/06 Note Period Ended 30/06 Period Ended 30/06 /2006 (unaudited) /2005 (unaudited) £ £ Net cash inflow from operating activities (29,938) (28,677)Returns on investment and servicing of finance:Interest received 2,674 4,382Interest payable (42) (32)Decrease in cash (27,306) (24,327) Notes to the Interim Report 1. Loss on ordinary activities before taxation The loss for the period is representative of operational overheads incurred inthe period. 2. Called up share Capital The issued share capital compromises 11,176,865 ordinary shares of 1p each,consisting of 200 shares of 1p each issued as two £1 subscriber shares onincorporation and converted into 1p shares on 23rd February 2004, 6,666,665ordinary shares of 1p each issued on 24th February 2004 and 4,510,000 ordinaryshares of 1p each issued on 18th March 2004. 3. Share premium The share premium represents: £ Premium arising on issues of ordinary shares in the period ended 31/12/2004 213,731Expenses of shares issues in the period ending 31/12/2004 (45,864) At 30th June 2006 167,867 4. Net assets per share The calculation of net assets per share is based on the net assets at the end ofthe period of £48,525 and on the number of ordinary shares in issue (11,176,865)at 30th June 2006. 5. Preparation of Interim Report The interim financial information for the period from 1 January 2006 to 30thJune 2006 was approved by the directors on 26 September 2006. 6. Financial information The financial information in this statement does not constitute statutoryaccounts within the meaning of section 240 of the Companies Act 1985. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Oct 20097:00 amRNSTrading Update
2nd Oct 20093:20 pmRNSHolding(s) in Company
2nd Oct 20093:04 pmRNSHolding(s) in Company
2nd Oct 200912:16 pmRNSHolding(s) in Company
2nd Oct 20098:53 amRNSHolding(s) in Company
30th Sep 20097:00 amRNSHolding(s) in Company
30th Sep 20097:00 amRNSHolding(s) in Company
25th Sep 20097:00 amRNSIssue of equity and acquisition
27th Aug 200911:56 amRNSAGM Statement
17th Jul 20099:00 amRNSAnnual Financial Report
16th Jul 20097:00 amRNSUK Distribution agreement for Genesis products
7th Jul 20097:00 amRNSFinal Results
4th Jun 20097:00 amRNSHolding(s) in Company
26th May 20097:00 amRNSLaunch of quality performance product
6th Apr 20093:03 pmRNSDirector/PDMR Shareholding
2nd Apr 200911:41 amRNSTrading Statement
20th Mar 20092:00 pmRNSChange of Adviser
12th Dec 20083:48 pmRNSDirector/PDMR Shareholding
27th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSTrading Statement
8th Oct 20083:57 pmRNSChange of Adviser Name
28th Aug 20081:24 pmRNSAGM Statement
12th Aug 200810:51 amRNSIssue of Equity / Directors'
18th Jul 200811:30 amRNSAnnual Report and Accounts
7th Jul 20087:00 amRNSFinal Results
12th Jun 20087:00 amRNSNotice of Results
10th Apr 20087:18 amRNSTrading Statement
12th Mar 200811:59 amRNSDirector/PDMR Shareholding
11th Mar 20082:19 pmRNSDirector/PDMR Shareholding
4th Mar 20087:01 amRNSDirector/PDMR Shareholding
10th Jan 20082:28 pmRNSHolding(s) in Company
7th Dec 20077:01 amRNSInterim Results
28th Sep 20077:01 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSNotifiable Interest
3rd Sep 20078:00 amRNSCompletion of Acquisition
3rd Sep 20078:00 amRNSTotal Voting Rights
31st Aug 20071:27 pmRNSDirectors' Dealings
31st Aug 20078:21 amRNSGenesis-CNS Interim Results
31st Aug 20078:00 amRNSCancellation - 31/08/07
30th Aug 200712:56 pmRNSResult of EGM
15th Aug 20078:23 amRNSCompliance with AIM Rule 26
13th Aug 200710:22 amRNSSchedule 1 -Omega Diagnostics
8th Aug 200712:26 pmRNSAGM Statement
6th Aug 20077:01 amRNSAcquisition and placing
6th Aug 20077:00 amRNSRestoration-Omega Diagnostics
6th Aug 20077:00 amRNSChange of Adviser
12th Jul 20071:30 pmRNSStatement re. Suspension
12th Jul 20071:30 pmRNSSuspension-Omega Diagnostics
26th Jun 20077:01 amRNSFinal Results
18th Apr 20074:50 pmRNSAccounting Reference Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.